- Report
- February 2026
- 250 Pages
Global
From €4019EUR$4,490USD£3,511GBP
- Report
- February 2026
- 250 Pages
Global
From €4019EUR$4,490USD£3,511GBP
- Report
- October 2025
- 250 Pages
Global
From €4019EUR$4,490USD£3,511GBP
- Report
- October 2025
- 250 Pages
Global
From €4019EUR$4,490USD£3,511GBP
- Report
- June 2025
- 363 Pages
Global
From €4019EUR$4,490USD£3,511GBP
- Report
- April 2026
- 396 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 382 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 274 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 138 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 178 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 341 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 390 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 370 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 401 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 479 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 272 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 294 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 294 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 271 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 282 Pages
Global
From €5237EUR$5,850USD£4,574GBP

The Genetic Disease market is a subset of the Genomics market that focuses on the diagnosis, treatment, and prevention of genetic diseases. It is a rapidly growing field, driven by advances in technology and the increasing availability of genetic testing. Companies in this market are developing new treatments and therapies for genetic diseases, as well as diagnostic tests and tools to identify and monitor them. They are also researching ways to prevent genetic diseases from occurring in the first place.
Companies in the Genetic Disease market include Illumina, Thermo Fisher Scientific, BGI, Genomic Health, and Invitae. These companies are developing innovative products and services to help diagnose, treat, and prevent genetic diseases. They are also investing in research and development to further advance the field. Show Less Read more